Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDeration

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Cancer

NCT02066961 ·Status: COMPLETED

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

Mitoxantrone, Prednisone Plus Sorafenib in Taxane-Refractory Metastatic Hormone Refractory Prostate Cancer (HRPC)

NCT00452387 ·Status: TERMINATED ·Phase: PHASE2

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT00668083 ·Status: COMPLETED

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

NCT00482807 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

NCT06473259 ·Status: RECRUITING

Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study

NCT07163910 ·Status: RECRUITING ·Phase: PHASE2

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

NCT04590976 ·Status: COMPLETED

A Long Term Safety Study With Atrasentan

NCT00127478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NCT03658486 ·Status: COMPLETED ·Phase: NA

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

NCT03678025 ·Status: RECRUITING ·Phase: PHASE3

Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer

NCT02913859 ·Status: UNKNOWN ·Phase: PHASE2

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

NCT03611686 ·Status: ACTIVE_NOT_RECRUITING

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

NCT06306612 ·Status: RECRUITING ·Phase: NA

Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer

NCT00104715 ·Status: COMPLETED ·Phase: PHASE3

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

NCT00002924 ·Status: COMPLETED

Non-Interventional Study PREVENT

NCT02155998 ·Status: COMPLETED

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

NCT01160705 ·Status: COMPLETED

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

NCT00134056 ·Status: COMPLETED ·Phase: PHASE3

AMG 386 and Abiraterone for Advanced Prostate Cancer

NCT01553188 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer

NCT03587285 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

NCT06734130 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progressive, PSMA-Positive Metastatic Castration-Resistant Prostate Cancer

NCT07311694 ·Status: RECRUITING ·Phase: PHASE3

PROCARE - PROstate Cancer Real World Evidence Registry

NCT06835218 ·Status: RECRUITING

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED